Ghazal Heidari-Hamedani

Ghazal Heidari-Hamedani, Ph.D., is an accomplished pharmacist and expert in pharmacovigilance and patient safety, currently serving as the Global Pharmacovigilance & Patient Safety Manager and Drug Safety Manager at Sobi - Swedish Orphan Biovitrum AB (publ) since April 2019. Prior experience includes a Drug Safety Consultant role at PharmaRelations and a Laboratory Specialist position at Prostatype Genomics AB. Ghazal has a robust background in oncology, particularly focusing on malignant tumors of pleura and malignant mesothelioma, and holds a PhD from Karolinska Institutet, complemented by a Master of Science in Molecular Life Science/Immunology from Stockholm University. Educational qualifications also include a Pharm.D. from Shiraz University of Medical Sciences. Ghazal's career reflects a strong commitment to improving patient safety and advancing drug safety practices.